TCL Archive Carter In Last Budget Asks Four Percent Increase For NCI, But Then Seeks $13.5 Million Rescission January 23, 1981
TCL Archive Retrospective Data Clean-Up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”. February 15, 2002
TCL Archive Patient Advocacy: Survivorship Programs Win Funds To form Model Programs December 13, 1996
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
